Nikita Shah - Mar 1, 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Executive Vice President
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Mar 1, 2024
Transactions value $
-$308,049
Form type
4
Date filed
3/5/2024, 04:35 PM
Previous filing
Feb 29, 2024
Next filing
Aug 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +29K +8.59% 366K Mar 1, 2024 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$83K -15.2K -4.15% $5.47 351K Mar 1, 2024 Direct F3
transaction AMRX Class A Common Stock Options Exercise +36.2K +10.33% 387K Mar 3, 2024 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$99.3K -18.2K -4.69% $5.47 369K Mar 3, 2024 Direct F3
transaction AMRX Class A Common Stock Options Exercise +45.9K +12.44% 415K Mar 3, 2024 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$126K -23K -5.54% $5.47 392K Mar 3, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -29K -50% $0.00 29K Mar 1, 2024 Class A Common Stock 29K Direct F2, F4
transaction AMRX Restricted Stock Units Options Exercise $0 -36.2K -33.33% $0.00 72.5K Mar 3, 2024 Class A Common Stock 36.2K Direct F2, F5
transaction AMRX Restricted Stock Units Options Exercise $0 -45.9K -25% $0.00 138K Mar 3, 2024 Class A Common Stock 45.9K Direct F2, F6
transaction AMRX Restricted Stock Units Award $0 +144K $0.00 144K Mar 4, 2024 Class A Common Stock 144K Direct F2, F7
transaction AMRX Performance-Based Restricted Stock Units Award $0 +287K $0.00 287K Mar 4, 2024 Class A Common Stock 287K Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F3 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
F4 March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F5 On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F6 On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F7 The restricted stock units vest in four equal installments beginning on March 4, 2025.
F8 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F9 Represents a performance-based restricted stock unit grant of 143,519 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period.